128 related articles for article (PubMed ID: 28205070)
1. Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma.
Itoh J; Ito A; Shimada S; Kawasaki Y; Kakoi N; Saito H; Mitsuzuka K; Watanabe M; Satoh M; Saito S; Arai Y
Glycoconj J; 2017 Apr; 34(2):267-273. PubMed ID: 28205070
[TBL] [Abstract][Full Text] [Related]
2. Ganglioside, disialosyl globopentaosylceramide (DSGb5), enhances the migration of renal cell carcinoma cells.
Kawasaki Y; Ito A; Kakoi N; Shimada S; Itoh J; Mitsuzuka K; Arai Y
Tohoku J Exp Med; 2015 May; 236(1):1-7. PubMed ID: 25864532
[TBL] [Abstract][Full Text] [Related]
3. Ganglioside disialosyl globopentaosylceramide is an independent predictor of PSA recurrence-free survival following radical prostatectomy.
Shimada S; Ito A; Kawasaki Y; Kakoi N; Taima T; Mitsuzuka K; Watanabe M; Saito S; Arai Y
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):199-205. PubMed ID: 24637536
[TBL] [Abstract][Full Text] [Related]
4. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
[TBL] [Abstract][Full Text] [Related]
5. Expression of Ganglioside Disialosyl Globopentaosyl Ceramide in Prostate Biopsy Specimens as a Predictive Marker for Recurrence after Radical Prostatectomy.
Sato M; Shimada S; Watanabe M; Kawasaki Y; Sato T; Morozumi K; Mitsuzuka K; Ito A
Tohoku J Exp Med; 2020 Sep; 252(1):1-8. PubMed ID: 32814720
[TBL] [Abstract][Full Text] [Related]
6. Microvascular and lymphovascular tumour invasion are associated with poor prognosis and metastatic spread in renal cell carcinoma: a validation study in clinical practice.
Bedke J; Heide J; Ribback S; Rausch S; de Martino M; Scharpf M; Haitel A; Zimmermann U; Pechoel M; Alkhayyat H; Shariat SF; Dombrowski F; Stenzl A; Burchardt M; Klatte T; Kroeger N
BJU Int; 2018 Jan; 121(1):84-92. PubMed ID: 28803448
[TBL] [Abstract][Full Text] [Related]
7. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable.
Shindo T; Masumori N; Kobayashi K; Fukuta F; Hirobe M; Tonooka A; Hasegawa T; Kitamura H; Tsukamoto T
BJU Int; 2013 May; 111(6):941-5. PubMed ID: 23350965
[TBL] [Abstract][Full Text] [Related]
9. Monoclonal antibody (5F3) defining renal cell carcinoma-associated antigen disialosyl globopentaosylceramide (V3NeuAcIV6NeuAcGb5), and distribution pattern of the antigen in tumor and normal tissues.
Ito A; Saito S; Masuko T; Oh-Eda M; Matsuura T; Satoh M; Nejad FM; Enomoto T; Orikasa S; Hakomori SI
Glycoconj J; 2001 Jun; 18(6):475-85. PubMed ID: 12084983
[TBL] [Abstract][Full Text] [Related]
10. High cytoplasmic expression of p27(Kip1) is associated with a worse cancer-specific survival in clear cell renal cell carcinoma.
Kruck S; Merseburger AS; Hennenlotter J; Scharpf M; Eyrich C; Amend B; Sievert KD; Stenzl A; Bedke J
BJU Int; 2012 May; 109(10):1565-70. PubMed ID: 21981759
[TBL] [Abstract][Full Text] [Related]
11. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.
Psutka SP; Feldman AS; McDougal WS; McGovern FJ; Mueller P; Gervais DA
Eur Urol; 2013 Mar; 63(3):486-92. PubMed ID: 22959191
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological significance of matrix metalloproteinase 2 protein expression in patients with renal cell carcinoma: A case-control study and meta-analysis.
Liu Q; Zhang GW; Zhu CY; Wei JX; Tian X; Li Y; Li XD
Cancer Biomark; 2016; 16(2):281-9. PubMed ID: 26756619
[TBL] [Abstract][Full Text] [Related]
13. Reduced expression of Raf-1 kinase inhibitory protein in renal cell carcinoma: a significant prognostic marker.
Moon A; Park JY; Sung JY; Park YK; Kim YW
Pathology; 2012 Oct; 44(6):534-9. PubMed ID: 22935977
[TBL] [Abstract][Full Text] [Related]
14. The significant immunological characteristics of peripheral blood neutrophil-to-lymphocyte ratio and Fas ligand expression incidence in nephrectomized tumor in late recurrence from renal cell carcinoma.
Sejima T; Iwamoto H; Morizane S; Hinata N; Yao A; Isoyama T; Saito M; Takenaka A
Urol Oncol; 2013 Oct; 31(7):1343-9. PubMed ID: 22153754
[TBL] [Abstract][Full Text] [Related]
15. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery.
Ishimura T; Sakai I; Hara I; Eto H; Miyake H
Int J Urol; 2004 May; 11(5):264-8. PubMed ID: 15147540
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
[TBL] [Abstract][Full Text] [Related]
17. Expression profiling and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in sporadic human renal cell carcinoma.
Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
Int J Clin Exp Pathol; 2014; 7(11):7597-609. PubMed ID: 25550796
[TBL] [Abstract][Full Text] [Related]
18. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
[TBL] [Abstract][Full Text] [Related]
19. Expression of MUC1 mucins inversely correlated with post-surgical survival of renal cell carcinoma patients.
Fujita K; Denda K; Yamamoto M; Matsumoto T; Fujime M; Irimura T
Br J Cancer; 1999 Apr; 80(1-2):301-8. PubMed ID: 10390012
[TBL] [Abstract][Full Text] [Related]
20. Cytoplasmic expression of pontin in renal cell carcinoma correlates with tumor invasion, metastasis and patients' survival.
Zhang X; Ren J; Yan L; Tang Y; Zhang W; Li D; Zang Y; Kong F; Xu Z
PLoS One; 2015; 10(3):e0118659. PubMed ID: 25751257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
